Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ardent Health (ARDT) EBITDA (2023 - 2025)

Ardent Health (ARDT) has 3 years of EBITDA data on record, last reported at -$278.1 million in Q3 2025.

  • For Q3 2025, EBITDA fell 42.76% year-over-year to -$278.1 million; the TTM value through Sep 2025 reached $63.7 million, up 112.02%, while the annual FY2024 figure was -$133.2 million, 55.63% up from the prior year.
  • EBITDA reached -$278.1 million in Q3 2025 per ARDT's latest filing, down from -$41.7 million in the prior quarter.
  • Across five years, EBITDA topped out at $440.1 million in Q4 2024 and bottomed at -$278.1 million in Q3 2025.
  • Average EBITDA over 3 years is -$42.2 million, with a median of -$56.6 million recorded in 2025.
  • The widest YoY moves for EBITDA: up 536.2% in 2024, down 138.3% in 2024.
  • A 3-year view of EBITDA shows it stood at -$100.9 million in 2023, then soared by 536.2% to $440.1 million in 2024, then tumbled by 163.19% to -$278.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$278.1 million in Q3 2025, -$41.7 million in Q2 2025, and -$56.6 million in Q1 2025.